Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-24 @ 4:43 PM
NCT ID:
NCT00548366
Eligibility Criteria:
Inclusion Criteria:
* Cirrhotic patients of any etiology with ascites from portal hypertension diagnosed by paracentesis,
* Age 18-75
* Clinical or radiographic (abdominal CT or ultrasound) estimate of moderate - severe ascites
* Spanish-speaking subjects will be eligible for participation
Exclusion Criteria:
* Active drug or alcohol abuse,
* Active complications of SBP, hepatic encephalopathy, or GI bleed within 2 weeks,
* Hemorrhagic ascites, malignant ascites,
* Creatinine \>2 mg/dL or CCl \< 30 mL/min,
* K \> 5.5 mmol/L,
* Diuretic refractory ascites
* Allergy to or intolerance of either spironolactone or furosemide
* Homelessness, incarceration, inability to follow up in clinic, or comply with diet.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00548366
Study Brief:
Protocol Section:
NCT00548366